Fall 2022 Bibliography

Fall Newsletter Header
Daavlin Banner


VSI Fall 2022 Newsletter
Bibliography and Sources

 Back to the Newsletter 

Avita Medical. AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® System. Avita Press Release. 2022.Sept 12.


Cobern J, Boren R. FDA approves new therapy for people living with skin-discoloration disorder vitiligo The cream treats an autoimmune condition that changes skin color.ABCNews.com. 2022.July 19.


IncyteCARES. https://www.incytecares.com/dermatology/opzelura/vitiligo/home.aspx

van Geel N, Taieb A. et al. Koebner’s phenomenon in vitiligo: European position paper. Pigment Cell & Melanoma Research. Vol. 24,3 (2011): 564-73. 2011 June 24, epub 2011 Mar 7. https://pubmed.ncbi.nlm.nih.gov/21324101/


Yadav A, Yadav P, et al. Tattoo for Camouflage: A New Cause of Tattoo Regret. Indian Dermatol Online J. 11(2):250-252. 2020 Mar 9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247660/

Copyright © 2022 Vitiligo Support International Inc. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.

A Vitiligo Support International, Inc. financial statement is available upon written request from the
Virginia Office of Consumer Affairs. Mail requests to:
Virginia Department of Agriculture and Consumer Services,
Office of Consumer Affairs,
P.O. Box 1163, Richmond, Virginia 23218.